These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
195 related articles for article (PubMed ID: 3276052)
21. Safe conversion from cyclosporine to azathioprine with improved renal function in pediatric renal transplantation. Kaiser BA; Lawless ST; Palmer JM; Dunn SP; Polinsky MS; Baluarte HJ Pediatr Nephrol; 1989 Oct; 3(4):401-5. PubMed ID: 2642107 [TBL] [Abstract][Full Text] [Related]
22. The selective use of antilymphocyte serum for cyclosporine treated patients with renal allograft dysfunction. Delmonico FL; Auchincloss H; Rubin RH; Russell PS; Tolkoff-Rubin N; Fang LT; Cosimi AB Ann Surg; 1987 Nov; 206(5):649-54. PubMed ID: 3314751 [TBL] [Abstract][Full Text] [Related]
23. Cyclosporin A as sole immunosuppressive agent for renal transplantation in children: effect on catch-up growth. Hodson EM; Knight JF; Sheil AG; Roy LP Transplant Proc; 1989 Feb; 21(1 Pt 2):1687-92. PubMed ID: 2652553 [No Abstract] [Full Text] [Related]
24. Comparison of kidney transplant survival between patients treated with cyclosporine and those treated with azathioprine and antithymocyte globulin. Cho SI; Bradley JW; Monaco AP; Tilney NL Am J Surg; 1984 Apr; 147(4):518-23. PubMed ID: 6370008 [TBL] [Abstract][Full Text] [Related]
25. The impact of cyclosporine therapy on the occurrence of infection in the renal transplant recipient. Tolkoff-Rubin NE; Rubin RH Transplant Proc; 1986 Apr; 18(2 Suppl 1):168-76. PubMed ID: 3008389 [No Abstract] [Full Text] [Related]
26. The use of low doses of cyclosporine, azathioprine, and prednisone in renal transplantation. First MR; Alexander JW; Wadhwa N; Penn I; Munda R; Fidler JP; Weiskittel P Transplant Proc; 1986 Apr; 18(2 Suppl 1):132-5. PubMed ID: 3515680 [No Abstract] [Full Text] [Related]
27. A controlled trial comparing sequential antilymphocyte sera and cyclosporine therapy to conventional therapy in renal transplant recipients. Cardella CJ; Harding ME; deVeber GA; Honey J; Cook GT Transplant Proc; 1987 Feb; 19(1 Pt 3):1996-7. PubMed ID: 3079065 [No Abstract] [Full Text] [Related]
29. Selective conversion from azathioprine to cyclosporin for steroid-resistant rejection in renal transplants: an alternative therapy. Crowson MC; Berisa F; McGonigle RJ; Adu D; Michael J; Barnes AD Nephrol Dial Transplant; 1989; 4(2):129-32. PubMed ID: 2496354 [TBL] [Abstract][Full Text] [Related]
30. Renal transplantation without prednisolone: effects of bone marrow tolerance azathioprine. Schulak JA; Moritz CE; Hricik DE Transplant Proc; 1989 Feb; 21(1 Pt 2):1709-11. PubMed ID: 2652560 [No Abstract] [Full Text] [Related]
31. Lipid abnormalities in renal transplant recipients treated with cyclosporine. Vathsala A; Weinberg RB; Schoenberg L; Grevel J; Dunn J; Goldstein RA; Van Buren CT; Lewis RM; Kahan BD Transplant Proc; 1989 Aug; 21(4):3670-3. PubMed ID: 2669278 [No Abstract] [Full Text] [Related]
34. Inhibition of chronic kidney allograft rejection by cyclosporine. Abbud-Filho M; Ramalho HJ; Barberato JB; Corrente JE; Zerati-Filho M; Verona CB; Martucci RC; Bezas AG Transplant Proc; 1989 Feb; 21(1 Pt 2):1660-2. PubMed ID: 2652544 [No Abstract] [Full Text] [Related]
35. High long-term graft survival rates in kidney transplantation with the sequential association of antithymocyte globulin and cyclosporine A monotherapy. Hourmant M; Buzelin F; Dubigeon P; Soulillou JP Transplant Proc; 1987 Feb; 19(1 Pt 3):2113-4. PubMed ID: 3079073 [No Abstract] [Full Text] [Related]
36. Cyclosporine experience in renal transplantation in children. Tejani A; Butt KM; Khawar MR; Hong JH; Fusi M; Pomrantz A Mt Sinai J Med; 1987 Sep; 54(6):467-74. PubMed ID: 3317018 [No Abstract] [Full Text] [Related]
37. Intermodal immunosuppression for cadaver renal transplantation: results using antilymphocyte globulin, azathioprine, cyclosporine, and prednisone. Halloran P; Ludwin D; Bear R; Aprile M; McQuarrie B; Poole R; White N Transplant Proc; 1987 Feb; 19(1 Pt 3):1931-2. PubMed ID: 3274454 [No Abstract] [Full Text] [Related]
38. Low incidence of rejection and in vitro donor-specific hyporesponsiveness using pretransplant ALG, low-dose cyclosporine, and steroids in kidney cadaveric transplantation. Griñó JM; Bas J; Gonzalez C; Castelao AM; Seron D; Mestre M; Buendia E; Sabate R; Diaz C; Alsina J Transplant Proc; 1990 Aug; 22(4):1367-8. PubMed ID: 2143855 [No Abstract] [Full Text] [Related]